Scott Kellen
CIK: 0001490476
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
DMAC
DiaMedica Therapeutics Inc.
Officer
Discretionary Trading P&L
Holdings
About Kellen Scott
Kellen Scott (SEC CIK 0001490476) files insider reports with the SEC as CFO & Secretary of DiaMedica Therapeutics Inc. (DMAC).
Signal8 holds 2 ownership filings by Kellen Scott, all Form 4s, filed between Jun 3, 2025 and Jun 3, 2026. Those filings report 2 transactions, from Jun 1, 2025 to Jun 1, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Kellen Scott's filings is in MINNEAPOLIS, MN.
Recent filings by Kellen Scott
Other insiders filing for DiaMedica Therapeutics Inc. (DMAC)
- Pauls Dietrich John, President & CEO
- Giuffre Randall Michael, Director
- Kuntz Richard, Director
- O'Connor Daniel J., Director
- Lewis Tanya, Director
- Semba Charles Pauling, Director